no statement of use filed
on 27 Nov 2023
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
97086440 filed on 21st Oct 2021
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use
No 97086440
No Service/Collective Mark
No 00160396-US
No
No
No
No
No
No
No
No
26.17.09 -
Curved line(s), band(s) or bar(s)
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
The mark consists of the word "TYCRUVA" in stylized font with curved lines above and below the letters "TYC".
| Status Date | Action Taken |
|---|---|
| 27th Nov 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 27th Nov 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 23rd Oct 2023 | ASSIGNED TO EXAMINER |
| 02th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 02th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 02th Aug 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 25th Apr 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 28th Feb 2023 | PUBLISHED FOR OPPOSITION |
| 28th Feb 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Feb 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
